Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079292 | SCV000111162 | benign | not specified | 2013-07-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000245788 | SCV000318646 | benign | Cardiovascular phenotype | 2015-06-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000456879 | SCV000562928 | benign | Long QT syndrome | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711224 | SCV001945193 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001711224 | SCV005234714 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000079292 | SCV001917876 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000079292 | SCV001959567 | benign | not specified | no assertion criteria provided | clinical testing |